Annual Operating Expenses
$255.77 M
+$52.44 M+25.79%
December 31, 2023
Summary
- As of February 7, 2025, ANIP annual total operating expenses is $255.77 million, with the most recent change of +$52.44 million (+25.79%) on December 31, 2023.
- During the last 3 years, ANIP annual operating expenses has risen by +$118.89 million (+86.85%).
- ANIP annual operating expenses is now at all-time high.
Performance
ANIP Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$104.95 M
+$30.14 M+40.28%
September 30, 2024
Summary
- As of February 7, 2025, ANIP quarterly total operating expenses is $104.95 million, with the most recent change of +$30.14 million (+40.28%) on September 30, 2024.
- Over the past year, ANIP quarterly operating expenses has increased by +$36.62 million (+53.58%).
- ANIP quarterly operating expenses is now at all-time high.
Performance
ANIP Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ANIP Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.8% | +53.6% |
| 3 y3 years | +86.8% | +83.8% |
| 5 y5 years | +174.5% | +193.1% |
ANIP Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +78.0% | at high | +120.8% |
| 5 y | 5-year | at high | +101.5% | at high | +249.2% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
ANI Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $104.95 M(+40.3%) |
| Jun 2024 | - | $74.81 M(+2.2%) |
| Mar 2024 | - | $73.22 M(+5.3%) |
| Dec 2023 | $255.77 M(+25.8%) | $69.52 M(+1.7%) |
| Sep 2023 | - | $68.33 M(+12.3%) |
| Jun 2023 | - | $60.82 M(+6.5%) |
| Mar 2023 | - | $57.09 M(+7.9%) |
| Dec 2022 | $203.33 M(+41.5%) | $52.89 M(+1.9%) |
| Sep 2022 | - | $51.91 M(+4.0%) |
| Jun 2022 | - | $49.89 M(+2.5%) |
| Mar 2022 | - | $48.65 M(+2.4%) |
| Dec 2021 | $143.69 M(+5.0%) | $47.53 M(+52.3%) |
| Sep 2021 | - | $31.21 M(-6.7%) |
| Jun 2021 | - | $33.46 M(+6.3%) |
| Mar 2021 | - | $31.49 M(-1.4%) |
| Dec 2020 | $136.89 M(+7.8%) | $31.93 M(+6.2%) |
| Sep 2020 | - | $30.06 M(-23.1%) |
| Jun 2020 | - | $39.08 M(+9.1%) |
| Mar 2020 | - | $35.81 M(+3.0%) |
| Dec 2019 | $126.97 M(+36.2%) | $34.77 M(+19.9%) |
| Sep 2019 | - | $29.01 M(-1.4%) |
| Jun 2019 | - | $29.43 M(-12.8%) |
| Mar 2019 | - | $33.76 M(+32.2%) |
| Dec 2018 | $93.19 M(+35.9%) | $25.54 M(+2.2%) |
| Sep 2018 | - | $24.98 M(+6.7%) |
| Jun 2018 | - | $23.41 M(+21.6%) |
| Mar 2018 | - | $19.25 M(+3.7%) |
| Dec 2017 | $68.58 M(+29.2%) | $18.56 M(+4.5%) |
| Sep 2017 | - | $17.75 M(+6.6%) |
| Jun 2017 | - | $16.65 M(+6.6%) |
| Mar 2017 | - | $15.62 M(+17.3%) |
| Dec 2016 | $53.08 M(+71.6%) | $13.32 M(-4.4%) |
| Sep 2016 | - | $13.94 M(-2.9%) |
| Jun 2016 | - | $14.35 M(+25.0%) |
| Mar 2016 | - | $11.48 M(+39.5%) |
| Dec 2015 | $30.93 M(+26.3%) | $8.23 M(-0.4%) |
| Sep 2015 | - | $8.26 M(+3.8%) |
| Jun 2015 | - | $7.96 M(+22.8%) |
| Mar 2015 | - | $6.48 M(-1.7%) |
| Dec 2014 | $24.49 M(+27.5%) | $6.59 M(+7.6%) |
| Sep 2014 | - | $6.13 M(-12.3%) |
| Jun 2014 | - | $6.99 M(+46.2%) |
| Mar 2014 | - | $4.78 M(+9.0%) |
| Dec 2013 | $19.21 M(-24.6%) | $4.39 M(+1.7%) |
| Sep 2013 | - | $4.32 M(-44.4%) |
| Jun 2013 | - | $7.76 M(+151.2%) |
| Mar 2013 | - | $3.09 M(-44.9%) |
| Dec 2012 | $25.47 M(-50.4%) | $5.60 M(+2.9%) |
| Sep 2012 | - | $5.45 M(-26.2%) |
| Jun 2012 | - | $7.38 M(+4.7%) |
| Mar 2012 | - | $7.05 M(-17.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $51.36 M(+11.5%) | $8.51 M(-35.6%) |
| Sep 2011 | - | $13.21 M(+0.5%) |
| Jun 2011 | - | $13.15 M(-20.3%) |
| Mar 2011 | - | $16.50 M(+24.0%) |
| Dec 2010 | $46.08 M(+17.0%) | $13.31 M(+17.9%) |
| Sep 2010 | - | $11.29 M(+10.3%) |
| Jun 2010 | - | $10.24 M(-8.9%) |
| Mar 2010 | - | $11.24 M(-56.1%) |
| Dec 2009 | $39.38 M(+80.7%) | $25.61 M(+421.5%) |
| Sep 2009 | - | $4.91 M(+3.7%) |
| Jun 2009 | - | $4.74 M(+14.7%) |
| Mar 2009 | - | $4.13 M(-24.5%) |
| Dec 2008 | $21.79 M(+137.6%) | $5.47 M(-19.3%) |
| Sep 2008 | - | $6.77 M(+22.3%) |
| Jun 2008 | - | $5.54 M(+38.0%) |
| Mar 2008 | - | $4.01 M(+71.4%) |
| Dec 2007 | $9.17 M(-16.6%) | $2.34 M(+6.9%) |
| Sep 2007 | - | $2.19 M(-18.9%) |
| Jun 2007 | - | $2.70 M(+39.2%) |
| Mar 2007 | - | $1.94 M(-52.8%) |
| Dec 2006 | $11.00 M(+15.0%) | $4.11 M(+307.9%) |
| Sep 2006 | - | $1.01 M(-59.2%) |
| Jun 2006 | - | $2.47 M(-27.5%) |
| Mar 2006 | - | $3.41 M(+80.4%) |
| Dec 2005 | $9.56 M(-22.6%) | $1.89 M(-7.6%) |
| Sep 2005 | - | $2.04 M(-25.1%) |
| Jun 2005 | - | $2.73 M(-5.8%) |
| Mar 2005 | - | $2.90 M(-32.1%) |
| Dec 2004 | $12.34 M(+102.0%) | $4.26 M(+43.8%) |
| Sep 2004 | - | $2.96 M(+12.5%) |
| Jun 2004 | - | $2.63 M(+6.2%) |
| Mar 2004 | - | $2.48 M(+46.7%) |
| Dec 2003 | $6.11 M(-8.0%) | $1.69 M(+15.4%) |
| Sep 2003 | - | $1.46 M(-10.0%) |
| Jun 2003 | - | $1.63 M(+22.5%) |
| Mar 2003 | - | $1.33 M(-41.0%) |
| Dec 2002 | $6.64 M(+46.6%) | $2.25 M(+27.7%) |
| Sep 2002 | - | $1.76 M(+17.4%) |
| Jun 2002 | - | $1.50 M(+36.2%) |
| Mar 2002 | - | $1.10 M(-23.4%) |
| Dec 2001 | $4.53 M(+23.7%) | $1.44 M(-1.4%) |
| Sep 2001 | - | $1.46 M(+60.6%) |
| Jun 2001 | - | $909.80 K(+26.0%) |
| Mar 2001 | - | $722.00 K(-25.7%) |
| Dec 2000 | $3.66 M(+128.4%) | $972.10 K(+42.8%) |
| Sep 2000 | - | $680.90 K(-54.5%) |
| Jun 2000 | - | $1.50 M(+189.8%) |
| Mar 2000 | - | $516.20 K(+58.2%) |
| Dec 1999 | $1.60 M(-42.3%) | - |
| Jun 1999 | - | $326.20 K |
| Dec 1998 | $2.78 M | - |
FAQ
- What is ANI Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual operating expenses year-on-year change?
- What is ANI Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly operating expenses year-on-year change?
What is ANI Pharmaceuticals annual total operating expenses?
The current annual operating expenses of ANIP is $255.77 M
What is the all time high annual operating expenses for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual total operating expenses is $255.77 M
What is ANI Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, ANIP annual total operating expenses has changed by +$52.44 M (+25.79%)
What is ANI Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of ANIP is $104.95 M
What is the all time high quarterly operating expenses for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly total operating expenses is $104.95 M
What is ANI Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, ANIP quarterly total operating expenses has changed by +$36.62 M (+53.58%)